Director/PDMR Shareholding | RNS | Ticker

/News/RNS

Director/PDMR Shareholding

RNS Announcement

RNS Number : 6083J

GlaxoSmithKline PLC

12 September 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

Details of PDMR/person closely associated with them ('PCA')

Name

Sir Andrew Witty

Position/status

CEO

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	8 (partnership shares)
£16.1550	8 (matching shares)

Aggregated information

Aggregated volume Price

16 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr R G Connor

Position/status

President, Global Manufacturing & Supply

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	8 (partnership shares)
£16.1550	8 (matching shares)

Aggregated information

Aggregated volume Price

16 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr S Dingemans

Position/status

CFO

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	8 (partnership shares)
£16.1550	8 (matching shares)

Aggregated information

Aggregated volume Price

16 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr N Hirons

Position/status

SVP, Global Ethics & Compliance

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	7 (partnership shares)
£16.1550	7 (matching shares)

Aggregated information

Aggregated volume Price

14 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr S A Hussain

Position/status

President, Global Pharmaceuticals

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	8 (partnership shares)
£16.1550	8 (matching shares)

Aggregated information

Aggregated volume Price

16 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr D S Redfern

Position/status

Chief Strategy Officer

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	7 (partnership shares)
£16.1550	7 (matching shares)

Aggregated information

Aggregated volume Price

14 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Ms C Thomas

Position/status

SVP, Human Resources

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	7 (partnership shares)
£16.1550	7 (matching shares)

Aggregated information

Aggregated volume Price

14 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr P C Thomson

Position/status

SVP, Communications & Government Affairs

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	8 (partnership shares)
£16.1550	8 (matching shares)

Aggregated information

Aggregated volume Price

16 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Dr P J T Vallance

Position/status

President, Pharmaceuticals R&D

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	8 (partnership shares)
£16.1550	8 (matching shares)

Aggregated information

Aggregated volume Price

16 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Ms E Walmsley

Position/status

CEO, GSK Consumer Healthcare

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	7 (partnership shares)
£16.1550	7 (matching shares)

Aggregated information

Aggregated volume Price

14 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

Details of PDMR/person closely associated with them ('PCA')

Name

Mrs V A Whyte

Position/status

Company Secretary

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Acquisition of Ordinary Shares under the Company's ShareReward Plan.

Price(s) and

volume(s)

Price(s)	Volume(s)
£16.1550	8 (partnership shares)
£16.1550	8 (matching shares)

Aggregated information

Aggregated volume Price

16 Ordinary shares

£16.1550

Date of the transaction

2016-09-09

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHELLFFQKFEBBQ

RNS metadata

Title: Director/PDMR Shareholding
Time: 17:58:05
Date: 12 Sept 2016
Category: Director/PDMR dealings
ID: 6083J